Local doctors point to nicotinamide (vitamin B3) — 500 mg twice daily — as a low‑cost way to reduce non‑melanoma skin cancer recurrence when used with sun protection.

A JAMA Pediatrics study finds about a 17% decline in infant egg allergy after earlier‑feeding guidance. Pediatricians advise parents to follow developmental cues and consult before introducing allergens.

Cigna will end coverage of GLP‑1 weight‑loss medications for employees on July 1, pushing staff toward cash payments and manufacturer or federal discount programs. The move follows price shifts driven by new oral pills and the Medicare Bridge.

A9600A would add ARFID to New York’s legal list of eating disorders after a 60–0 Senate vote, a change sponsors say will expand coverage and awareness.

A UK MRI study links napping, insomnia and short sleep to white‑matter lesions tied to dementia. NYC sleep doctors say shaping daytime routines may help protect the brain.

Local reporting says a rare tick‑borne bacterium was detected in Suffolk County; state and county health teams have ramped up surveillance. Here’s what Long Islanders should know.

State lawmakers approved a law requiring monthly heavy‑metal testing and public posting of results for baby food and, for the first time, infant formula.

A state‑funded, $32 million, 60‑bed recovery center opened on Wards Island to provide medication‑assisted treatment and stabilization for men in early recovery.

New York’s state lab detected Borrelia mayonii in Herkimer County ticks and a federal report ties a locally acquired case to the finding. Officials urge vigilance this tick season.

Stony Brook Children’s Hospital broke ground on a $55M pediatric emergency department that will add exam rooms, critical-care bays and telemedicine capacity for Long Island families.

NYC Health + Hospitals is opening a second Bridge to Home site in Crown Heights, adding 50 private rooms and 24/7 clinical care to help residents secure permanent housing.

CVS Caremark will add Eli Lilly’s Zepbound back to some commercial formularies on Oct. 1, 2026, reversing a mid‑2025 exclusion that limited patient options.

NYU's Dr. Jinsy Andrews breaks down gene-targeted ALS advances and offers practical brain-health tips for patients and caregivers.